DA Schwartz, DS Van Fossen, CS Davis, RA Helmers, CS Dayton, LF Burmeister and GW Hunninghake
Department of Internal Medicine, Department of Veterans Administration Medical Center, Iowa City, Iowa.

Idiopathic pulmonary fibrosis (IPF) is a progressive form of lung disease with a median survival of less than 5 yr. To address the progressive nature of this disease process, we investigated the determinants of decrements in lung function in patients with IPF. We prospectively evaluated 39 subjects with IPF. Our study subjects were followed for an average of 2 yr (range, 49 to 1,883 days) and lung function was measured on at least two separate occasions (mean = 9.1 separate tests) during the follow-up period. Since IPF is characterized by reduced lung volume and abnormal gas exchange, our analysis focused on the determinants of total lung capacity (TLC) and diffusing capacity of carbon monoxide (DLCO) during the period of observation. Although, on average, there was a 5.3% increase in the TLC and a 9.8% increase in DLCO between the first and last measure of lung function, 25% of the study population experienced a decline in the TLC and 28% of the study population experienced a decline in the DLCO. Decrements in TLC were independently associated with severe dyspnea (p = 0.01) and treatment with cyclophosphamide (p = 0.03). Decrements in DLCO were significantly and independently associated with more pack-years of cigarette smoking (p = 0.02), moderate (p = 0.03) or severe (p = 0.02) dyspnea, and treatment with cyclophosphamide (p = 0.0002). These findings indicate that several clinical characteristics are independently associated with subsequent declines in TLC and DLCO in patients with IPF.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. J. Greenlee, Z. Werb, and F. Kheradmand Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted Physiol Rev, January 1, 2007; 87(1): 69 - 98. [Abstract] [Full Text] [PDF]

				N. Walter, H. R. Collard, and T. E. King Jr. Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proceedings of the ATS, January 1, 2006; 3(4): 330 - 338. [Abstract] [Full Text] [PDF]

				K. R. F. M.D. and G. G. Hunninghake Smoking: An Injury with Many Lung Manifestations Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1070 - 1071. [Full Text] [PDF]

				M. P. Steele, M. C. Speer, J. E. Loyd, K. K. Brown, A. Herron, S. H. Slifer, L. H. Burch, M. M. Wahidi, J. A. Phillips III, T. A. Sporn, et al. Clinical and Pathologic Features of Familial Interstitial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1146 - 1152. [Abstract] [Full Text] [PDF]

				T. C. McLoud Role of High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis: The Final Word? Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 408 - 409. [Full Text] [PDF]

				F. J. Martinez, S. Safrin, D. Weycker, K. M. Starko, W. Z. Bradford, T. E. King Jr, K. R. Flaherty, D. A. Schwartz, P. W. Noble, G. Raghu, et al. The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis Ann Intern Med, June 21, 2005; 142(12_Part_1): 963 - 967. [Abstract] [Full Text] [PDF]

				J J Egan, F J Martinez, A U Wells, and T Williams Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification Thorax, April 1, 2005; 60(4): 270 - 273. [Full Text] [PDF]

				T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Eur. Respir. J., January 1, 2005; 25(1): 96 - 103. [Abstract] [Full Text] [PDF]

				K. R. Flaherty, J. A. Mumford, S. Murray, E. A. Kazerooni, B. H. Gross, T. V. Colby, W. D. Travis, A. Flint, G. B. Toews, J. P. Lynch III, et al. Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 543 - 548. [Abstract] [Full Text] [PDF]

				H Mukae, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, and S Kohno Raised plasma concentrations of {alpha}-defensins in patients with idiopathic pulmonary fibrosis Thorax, July 1, 2002; 57(7): 623 - 628. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 277 - 304. [Full Text] [PDF]

				T. E. KING JR., M. I. SCHWARZ, K. BROWN, J. A. TOOZE, T. V. COLBY, J. A. WALDRON JR., A. FLINT, W. THURLBECK, and R. M. CHERNIACK Idiopathic Pulmonary Fibrosis . Relationship between Histopathologic Features and Mortality Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1025 - 1032. [Abstract] [Full Text] [PDF]

				T. J. Gross and G. W. Hunninghake Idiopathic Pulmonary Fibrosis N. Engl. J. Med., August 16, 2001; 345(7): 517 - 525. [Full Text] [PDF]

				G. W. HUNNINGHAKE, M. B. ZIMMERMAN, D. A. SCHWARTZ, T. E. KING JR., J. LYNCH, R. HEGELE, J. WALDRON, T. COLBY, N. MULLER, D. LYNCH, et al. Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 193 - 196. [Abstract] [Full Text] [PDF]

				N. MOGULKOC, M. H. BRUTSCHE, P. W. BISHOP, S. M. GREAVES, A. W. HORROCKS, and J. J. EGAN Pulmonary Function in Idiopathic Pulmonary Fibrosis and Referral for Lung Transplantation Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 103 - 108. [Abstract] [Full Text] [PDF]

				H. TAKAHASHI, T. FUJISHIMA, H. KOBA, S. MURAKAMI, K. KUROKAWA, Y. SHIBUYA, M. SHIRATORI, Y. KUROKI, and S. ABE Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease Extent Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1109 - 1114. [Abstract] [Full Text]

				K. B. Baumgartner, J. M. Samet, D. B. Coultas, C. A. Stidley, W. C. Hunt, T. V. Colby, J. A. Waldron, and Collaborating Centers Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study Am. J. Epidemiol., August 15, 2000; 152(4): 307 - 315. [Abstract] [Full Text] [PDF]

				D. A. Zisman, J. P. Lynch III, G. B. Toews, E. A. Kazerooni, A. Flint, and F. J. Martinez Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis : A Prospective Study in Patients Who Failed To Respond to Corticosteroids Chest, June 1, 2000; 117(6): 1619 - 1626. [Abstract] [Full Text] [PDF]

				T. Y. Martinez, C. A. C. Pereira, M. L. dos Santos, R. M. Ciconelli, S. M. Guimaraes, and J. A. B. Martinez Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis Chest, June 1, 2000; 117(6): 1627 - 1632. [Abstract] [Full Text] [PDF]

				A. PARDO, R. BARRIOS, M. GAXIOLA, L. SEGURA-VALDEZ, G. CARRILLO, A. ESTRADA, M. MEJÍA, and M. SELMAN Increase of Lung Neutrophils in Hypersensitivity Pneumonitis Is Associated with Lung Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1698 - 1704. [Abstract] [Full Text]

				T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]

				D. M Mitchell and A. Woodcock Introduction Thorax, August 1, 1999; 54(90002): S1 - 1. [PDF]

				D. W Mapel, W. C Hunt, R. Utton, K. B Baumgartner, J. M Samet, and D. B Coultas Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts Thorax, June 1, 1998; 53(6): 469 - 476. [Abstract] [Full Text]

				S. E. GAY, E. A. KAZEROONI, G. B. TOEWS, J. P. LYNCH III, B. H. GROSS, P. N. CASCADE, D. L. SPIZARNY, A. FLINT, M. ANTHONY SCHORK, R. I. WHYTE, et al. Idiopathic Pulmonary Fibrosis . Predicting Response to Therapy and Survival Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1063 - 1072. [Abstract] [Full Text] [PDF]

				P. A. WARD and G. W. HUNNINGHAKE Lung Inflammation and Fibrosis Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S123 - S129. [Full Text] [PDF]

				A. U. WELLS, D. M. HANSELL, P. L. HASLAM, M. B. RUBENS, J. CAILES, C. M. BLACK, and R. M. du BOIS Bronchoalveolar Lavage Cellularity . Lone Cryptogenic Fibrosing Alveolitis Compared with the Fibrosing Alveolitis of Systemic Sclerosis Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1474 - 1482. [Abstract] [Full Text]

				B. T. SOCIETY and S. O. C. COMMITTEE The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults---British Thoracic Society recommendations Thorax, April 1, 1990; 54(90001): 1S - 28. [Full Text]